Hi everyone,

I am digging deeper into outlier detection and handling for untargeted clinical metabolomics (RP LCMS).

To be honest, I am not so satisfied with the outlier definition based on "obviously deviating on PCA", and with the subsequent handling being "arbitrary removal of the sample".

I have a pilot study with 37 pairs of matched cases and controls. I cannot afford to delete all the pairs that "deviate" on the PCA based on visual -and therefore subjective- inspection.

I was thinking of double checking the compounds responsible for deviation as a starting point, etc.

Then I thought that our wonderful community here must have good ideas on how to best detect and handle outliers. :D

Any thoughts? What is your preferred workflow?

Thank you,

Best

Julie

More Julie Courraud's questions See All
Similar questions and discussions